🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Interesting analyis led by Mark Corkum MD, MSc, FRCPC, DRCPSC and Glenn Bauman, MD. Further analysis will be needed in the future for more robust conclusions

Oure recently published correspondence at JCO - Brachytherapy and Androgen-Deprivation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer: Not Necessarily an Either/Or Decision ascopubs.org/doi/pdf/10.120… Dr Kevin Martell

Yes, Urinary retention risk seems to increase in a synergistic way when more than one risk factor is present. I agree that leaving the catheter for a few days for this high-risk group is okay. In my experience, most of patients prefer to take the chance 😂

Is hypofractionated WPRT safe in high-ish risk prostate cancer patients treated with HDR-BT boost? Check out the HOPE-Trial below! To our knowledge, this is the first RCT investigating this question. rdcu.be/b8jLy Dr Kevin Martell Glenn Bauman, MD George Rodrigues @axarifin

Awesome event coming up. I’d like to thank Andrey and LACOG committee for the invitation. Just point out that I currently live and work in London-Canada, not UK. See you soon!

Great translational study led by stellar Dr Stanley Liu lab that adds to the literature by suggesting that HDR-BT induces different immune activation to EBRT in G9 PCa. This could be one of the explanations for early MFS curve separation in previous analysis. thegreenjournal.com/article/S0167-…

Check out our new paper on ISBT in vaginal primaries. A Combined analysis of LHSC and Sunnybrook patients and likely the biggest analysis on vaginal cancers treated with 3D ISBT. Great job Chris Goodman! sciencedirect.com/science/articl…

The privilege was ours to share a couple hours with you during this meeting. Thank you for your great input and participation.

Any consideration Dr. Andrew Loblaw Gerard Morton?

2021 Curietherapies annual meeting will be help virtually 21-23 of May. This year's focus is Brachytherapy: Pushing the limits of ablative therapy. The Meeting program is now available: curietherapi.es/atelier/brachy… #ThisisBrachytherapy #Curietherapies2021

Great discussion. Thank you for the invitation Curietherapi.es. Too bad the meeting was not presencial (due to obvious reasons)

Exactly 70 years ago the so called “Cobalt Bomb” treated the first cancer patient here at Victoria Hospital, here in London, Canada. Millions of cancer patients have benefited from this technology since then. Celebrating this event by enjoying a cool cookie London Health Sciences Centre

TROG 03.04 Radar analysis on % of grade4 disease and survival outcomes in prostate cancer. Looks like the absolute % G4 continues to well associate with survival outcomes. A new logical ISUP classification is suggested. Dr Kevin Martell Dr. Andrew Loblaw pdf.sciencedirectassets.com/314028/AIP/1-s…

Our fresh systematic review and meta-analysis on Brachy boost in GG5 prostate cancers. Not a tonne of evidence in this space and prospective data is needed. For now, this represents the most comprehensive data available doi.org/10.1016/j.ctro…

Now online IJROBP - The Red Journal Early results of the randomized Hope trial. Is ultra-HypoRT to the pelvis post prostate BT as well tolerated as conventional RT? sciencedirect.com/science/articl… Alfonso Gomez-Iturriaga Dr Kevin Martell Dr Stanley Liu

🔥Hot off the press European Urology Oncology IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc authors.elsevier.com/c/1jOzs9Cfv--d… Thankful for mentors Shankar Siva Alex Louie MD, PhD Rohann Correa

Excellent opportunity for trainees and early staff in RadOnc and MedPhysics to sharpen their knowledge and above all their manual skills in GU and GYN brachytherapy with the stellar Western University BT team Rohann Correa Vikram Velker Joelle and others

More data will come out from this collaborative effort and arguably the CLIMBER piece will be the most interesting one. In this publication we report acute/subacute associated with SBRT with boost to PSMA/mpMRI defined DILs. redjournal.org/article/S0360-… Kudos to Dr Glenn Bauman #LHSC